Literature DB >> 30193196

Comparative studies on amphotericin B nanosuspensions prepared by a high pressure homogenization method and an antisolvent precipitation method.

Yixian Zhou1, Qiuyu Fang2, Boyi Niu1, Biyuan Wu1, Yiting Zhao1, Guilan Quan3, Xin Pan4, Chuanbin Wu1.   

Abstract

Amphotericin B (AmB) is a widely used polyene antifungal agent; however, its poor solubility limits its clinical application. In this study, AmB nanosuspensions were prepared by a high pressure homogenization method (AmB-HPH) and an antisolvent precipitation method (AmB-AP) to improve the drug solubility. To reveal the distinct influences of these two different preparation methods, systematic comparisons of particle size, crystalline state, wettability, in vitro dissolution and in vivo pharmacokinetics on the properties of AmB-HPH and AmB-AP were performed. The results indicated that AmB-AP was in an amorphous state, exhibiting higher saturation solubility and dissolution rate than those of AmB-HPH in the crystalline state. However, the relative bioavailability of AmB-HPH was higher than that of AmB-AP in vivo, which was likely attributed to its better stability. In conclusion, both AmB-HPH and AmB-AP can enhance the solubility and bioavailability of AmB, but the stability of the nanosuspension prepared by the anti-solvent precipitation method should be carefully considered.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Amphotericin B; Antisolvent precipitation; Bioavailability; High pressure homogenization; Nanosuspensions; Solubility

Mesh:

Substances:

Year:  2018        PMID: 30193196     DOI: 10.1016/j.colsurfb.2018.08.016

Source DB:  PubMed          Journal:  Colloids Surf B Biointerfaces        ISSN: 0927-7765            Impact factor:   5.268


  8 in total

Review 1.  Nanotechnology based solutions for anti-leishmanial impediments: a detailed insight.

Authors:  Humzah Jamshaid; Fakhar Ud Din; Gul Majid Khan
Journal:  J Nanobiotechnology       Date:  2021-04-15       Impact factor: 10.435

2.  Development of Abiraterone Acetate Nanocrystal Tablets to Enhance Oral Bioavailability: Formulation Optimization, Characterization, In Vitro Dissolution and Pharmacokinetic Evaluation.

Authors:  Yuanfen Liu; Yuqi Li; Pengcheng Xu; Yan Shen; Baoqiang Tang; Qiyue Wang
Journal:  Pharmaceutics       Date:  2022-05-26       Impact factor: 6.525

3.  Preparation, Characterization, and Evaluation of Breviscapine Nanosuspension and Its Freeze-Dried Powder.

Authors:  Ting Zhang; Xixi Li; Juewen Xu; Jingbao Shao; Meihong Ding; Senlin Shi
Journal:  Pharmaceutics       Date:  2022-04-24       Impact factor: 6.525

Review 4.  Lipid Systems for the Delivery of Amphotericin B in Antifungal Therapy.

Authors:  Célia Faustino; Lídia Pinheiro
Journal:  Pharmaceutics       Date:  2020-01-01       Impact factor: 6.321

5.  Rilpivirine-associated aggregation-induced emission enables cell-based nanoparticle tracking.

Authors:  Insiya Z Mukadam; Jatin Machhi; Jonathan Herskovitz; Mahmudul Hasan; Maxim D Oleynikov; Wilson R Blomberg; Denis Svechkarev; Aaron M Mohs; You Zhou; Prasanta Dash; JoEllyn McMillan; Santhi Gorantla; Jered Garrison; Howard E Gendelman; Bhavesh D Kevadiya
Journal:  Biomaterials       Date:  2019-12-07       Impact factor: 12.479

Review 6.  Advanced modification of drug nanocrystals by using novel fabrication and downstream approaches for tailor-made drug delivery.

Authors:  Tao Liu; Xinxin Yu; Haipeng Yin; Jan P Möschwitzer
Journal:  Drug Deliv       Date:  2019-12       Impact factor: 6.419

7.  Insight into the Formation of Glimepiride Nanocrystals by Wet Media Milling.

Authors:  Djordje Medarević; Svetlana Ibrić; Elisavet Vardaka; Miodrag Mitrić; Ioannis Nikolakakis; Kyriakos Kachrimanis
Journal:  Pharmaceutics       Date:  2020-01-09       Impact factor: 6.321

Review 8.  Nanoparticles for antiparasitic drug delivery.

Authors:  Yuzhu Sun; Dongmei Chen; Yuanhu Pan; Wei Qu; Haihong Hao; Xu Wang; Zhenli Liu; Shuyu Xie
Journal:  Drug Deliv       Date:  2019-12       Impact factor: 6.419

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.